Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece.
about
cAMP signalling in trypanosomatids: role in pathogenesis and as a drug target.Disease Severity Prediction by Spirometry in Adults with Visceral Leishmaniasis from Minas Gerais, Brazil.Nanostructured delivery systems with improved leishmanicidal activity: a critical review.VCAM-1 and ICAM-1 Serum Levels as Markers of Relapse in Visceral Leishmaniasis.Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia.Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasis.
P2860
Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Current clinical, laboratory, ...... retrospective study in Greece.
@en
Current clinical, laboratory, ...... retrospective study in Greece.
@nl
type
label
Current clinical, laboratory, ...... retrospective study in Greece.
@en
Current clinical, laboratory, ...... retrospective study in Greece.
@nl
prefLabel
Current clinical, laboratory, ...... retrospective study in Greece.
@en
Current clinical, laboratory, ...... retrospective study in Greece.
@nl
P2093
P1476
Current clinical, laboratory, ...... retrospective study in Greece.
@en
P2093
Aggelos Stefos
George N Dalekos
Gregory Spanakos
Konstantinos Makaritsis
Nikolaos V Sipsas
Sarah P Georgiadou
Stergios Skrimpas
P356
10.1016/J.IJID.2015.02.021
P577
2015-03-03T00:00:00Z